OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer proteogenomics: current impact and future prospects
D.R. Mani, Karsten Krug, Bing Zhang, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 298-313
Closed Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Multi-Omics Profiling for Health
Mohan Babu, M Snyder
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 6, pp. 100561-100561
Open Access | Times Cited: 136

Proteogenomic data and resources for pan-cancer analysis
Yize Li, Yongchao Dou, Felipe da Veiga Leprevost, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1397-1406
Open Access | Times Cited: 82

Pharmacogenomics: Driving Personalized Medicine
Wolfgang Sadée, Daqing Wang, Katherine E. Hartmann, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 4, pp. 789-814
Open Access | Times Cited: 79

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3945-3967.e26
Open Access | Times Cited: 69

Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 65

Pan-cancer proteogenomics expands the landscape of therapeutic targets
Sara R. Savage, Xinpei Yi, Jonathan T. Lei, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4389-4407.e15
Open Access | Times Cited: 22

The 2023 Report on the Proteome from the HUPO Human Proteome Project
Gilbert S. Omenn, Lydie Lane, Christopher M. Overall, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 2, pp. 532-549
Open Access | Times Cited: 15

Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
Hui Long, Jiafu Zhou, Caicun Zhou, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 152-152
Open Access | Times Cited: 1

Enhanced Competition at the Nano–Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes
Shadi Ferdosi, Alexey Stukalov, Moaraj Hasan, et al.
Advanced Materials (2022) Vol. 34, Iss. 44
Open Access | Times Cited: 43

Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we?
Emma L. Boys, Jia Liu, Phillip J. Robinson, et al.
PROTEOMICS (2022) Vol. 23, Iss. 7-8
Open Access | Times Cited: 38

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues
Jennifer G. Abelin, Erik J. Bergstrom, Keith Rivera, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35

Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma
Han Hong, Xi Chen, Honggang Wang, et al.
PROTEOMICS (2023) Vol. 23, Iss. 9
Closed Access | Times Cited: 32

De novo peptide sequencing with InstaNovo: Accurate, database-free peptide identification for large scale proteomics experiments
Kevin Eloff, Konstantinos Kalogeropoulos, Oliver Morell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 25

A proteogenomics data-driven knowledge base of human cancer
Yuxing Liao, Sara R. Savage, Yongchao Dou, et al.
Cell Systems (2023) Vol. 14, Iss. 9, pp. 777-787.e5
Closed Access | Times Cited: 24

Precision cancer medicine: Concepts, current practice, and future developments
Anders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 455-481
Open Access | Times Cited: 22

Advances in Integrated Multi-omics Analysis for Drug-Target Identification
Peiling Du, Rui Fan, Nana Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 692-692
Open Access | Times Cited: 11

Omics-based molecular classifications empowering in precision oncology
Zhaokai Zhou, Ting Lin, Shuang Chen, et al.
Cellular Oncology (2024) Vol. 47, Iss. 3, pp. 759-777
Closed Access | Times Cited: 8

Proteomics: An In‐Depth Review on Recent Technical Advances and Their Applications in Biomedicine
Jing Liang, Jun Tian, Huadong Zhang, et al.
Medicinal Research Reviews (2025)
Closed Access | Times Cited: 1

Evaluating Linear Ion Trap for MS3-Based Multiplexed Single-Cell Proteomics
Junho Park, Fengchao Yu, James Fulcher, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 3, pp. 1888-1898
Open Access | Times Cited: 17

Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer
Tasuku Matsuoka, Masakazu Yashiro
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5880-5880
Open Access | Times Cited: 6

Bimodality in pan-cancer proteomics reveals new opportunities for biomarker discovery
Wen Jiang, Damián E. Bikiel, Jan Zaucha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
Chaston Weaver, Khaled Bin Satter, Katherine P. Richardson, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2953-2953
Open Access | Times Cited: 25

Page 1 - Next Page

Scroll to top